BR112018010671A8 - dispositivos e métodos de distribuição de fármaco com mudança de forma - Google Patents
dispositivos e métodos de distribuição de fármaco com mudança de formaInfo
- Publication number
- BR112018010671A8 BR112018010671A8 BR112018010671A BR112018010671A BR112018010671A8 BR 112018010671 A8 BR112018010671 A8 BR 112018010671A8 BR 112018010671 A BR112018010671 A BR 112018010671A BR 112018010671 A BR112018010671 A BR 112018010671A BR 112018010671 A8 BR112018010671 A8 BR 112018010671A8
- Authority
- BR
- Brazil
- Prior art keywords
- drug delivery
- shape
- delivery devices
- methods
- changing drug
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts, ocular implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
a presente invenção refere-se à distribuição de fármaco usando fármacos que afetam o bio, particularmente, com dispositivos de distribuição de fármaco com mudança de forma. as modalidades são incluídas para depósitos para a distribuição de um agente terapêutico que mudam de um estado alongado ex vivo para uma bobina in vivo onde o agente é liberado.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562260068P | 2015-11-25 | 2015-11-25 | |
US201662319033P | 2016-04-06 | 2016-04-06 | |
PCT/US2016/063633 WO2017091749A1 (en) | 2015-11-25 | 2016-11-23 | Shape changing drug delivery devices and methods |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112018010671A2 BR112018010671A2 (pt) | 2018-11-13 |
BR112018010671A8 true BR112018010671A8 (pt) | 2019-02-26 |
Family
ID=57590829
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112018010671A BR112018010671A8 (pt) | 2015-11-25 | 2016-11-23 | dispositivos e métodos de distribuição de fármaco com mudança de forma |
Country Status (10)
Country | Link |
---|---|
US (4) | US10420724B2 (pt) |
EP (1) | EP3380077A1 (pt) |
JP (1) | JP2018536484A (pt) |
KR (1) | KR20180086468A (pt) |
CN (1) | CN108601725B (pt) |
AU (1) | AU2016361579B2 (pt) |
BR (1) | BR112018010671A8 (pt) |
CA (1) | CA3006303C (pt) |
IL (1) | IL259530A (pt) |
WO (1) | WO2017091749A1 (pt) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6882186B2 (ja) | 2014-12-15 | 2021-06-02 | ザ ジョーンズ ホプキンズ ユニバーシティThe Johns Hopkins University | スニチニブ製剤及び眼の障害の治療におけるその使用に対する方法 |
EP3288626A4 (en) | 2015-04-27 | 2019-01-23 | Reflex Medical Inc. | SYSTEMS AND METHODS FOR SYMPATHETIC CARDIO-PULMONARY NEUROMODULATION |
US11458041B2 (en) | 2015-10-08 | 2022-10-04 | Ocular Therapeutix, Inc. | Punctal plug and bioadhesives |
BR112018009644A2 (pt) | 2015-11-12 | 2018-11-06 | Graybug Vision Inc | micropartículas agregantes sólidas modificadas na superfície, material injetável, processo para preparação de micropartículas agregantes sólidas modificadas na superfície, método para tratamento de um distúrbio ocular, e, uso de micropartículas agregantes sólidas modificadas na superfície |
JP2018536484A (ja) | 2015-11-25 | 2018-12-13 | インセプト・リミテッド・ライアビリティ・カンパニーIncept,Llc | 形状変化する薬物送達デバイス及び方法 |
WO2017139487A1 (en) | 2016-02-09 | 2017-08-17 | Northwind Medical, Inc. | Methods, agents, and devices for local neuromodulation of autonomic nerves |
US11154547B2 (en) | 2016-06-29 | 2021-10-26 | Tulavi Therapeutics, Inc. | Treatment of sepsis and related inflammatory conditions by local neuromodulation of the autonomic nervous system |
EP3515406A1 (en) | 2016-09-23 | 2019-07-31 | Incept, LLC | Intracameral drug delivery depots |
AU2018265415A1 (en) | 2017-05-10 | 2019-10-31 | Graybug Vision, Inc. | Extended release microparticles and suspensions thereof for medical therapy |
CN108744048B (zh) * | 2018-06-29 | 2020-11-13 | 重庆科技学院 | 一种可实现自卷曲的双层水凝胶及其制备方法 |
EP3817786A4 (en) | 2018-07-02 | 2022-03-23 | Tulavi Therapeutics, Inc. | METHODS AND DEVICES FOR IN SITU FORMED NERVE CAP |
CN109350355B (zh) * | 2018-11-30 | 2023-09-12 | 西安市第四医院 | 一种smile手术来源角膜基质透镜泪道栓及其制备方法 |
US11523896B2 (en) | 2019-05-02 | 2022-12-13 | Kevin L. Waltz | Ocular protection ring |
CN111150545A (zh) * | 2020-01-02 | 2020-05-15 | 首都医科大学附属北京同仁医院 | 一种相变降温支架及其制备方法和相变降温组合支架 |
JP7451732B2 (ja) | 2020-02-06 | 2024-03-18 | オキュラ セラピューティクス,インコーポレイテッド | 眼疾患を治療するための組成物及び方法 |
BR112022018815A2 (pt) | 2020-03-25 | 2022-11-29 | Ocular Therapeutix Inc | Implante ocular contendo um inibidor de tirosina cinase |
IL300089A (en) | 2020-09-24 | 2023-03-01 | Ocular Therapeutix Inc | Sustained-release biological intracanalicular inserts comprising hydrogel and cyclosporine |
WO2024064359A2 (en) * | 2022-09-25 | 2024-03-28 | Albert Ludwig University Of Freiburg | Marine polysaccharide networks |
Family Cites Families (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1014335A (en) | 1910-11-10 | 1912-01-09 | Union Typewriter Co | Type-writing machine. |
US3640741A (en) | 1970-02-24 | 1972-02-08 | Hollister Inc | Composition containing gel |
US3865108A (en) | 1971-05-17 | 1975-02-11 | Ortho Pharma Corp | Expandable drug delivery device |
US4002173A (en) | 1974-07-23 | 1977-01-11 | International Paper Company | Diester crosslinked polyglucan hydrogels and reticulated sponges thereof |
DE2437629C3 (de) | 1974-08-05 | 1978-09-21 | Basf Ag, 6700 Ludwigshafen | Verfahren zur Herstellung von unlöslichen in Wasser nur wenig quellbaren Polymerisaten von N-Vinyllactamen |
US4014335A (en) | 1975-04-21 | 1977-03-29 | Alza Corporation | Ocular drug delivery device |
US4207893A (en) | 1977-08-29 | 1980-06-17 | Alza Corporation | Device using hydrophilic polymer for delivering drug to biological environment |
US4484922A (en) | 1981-06-25 | 1984-11-27 | Rosenwald Peter L | Occular device |
US4741872A (en) | 1986-05-16 | 1988-05-03 | The University Of Kentucky Research Foundation | Preparation of biodegradable microspheres useful as carriers for macromolecules |
US5160745A (en) | 1986-05-16 | 1992-11-03 | The University Of Kentucky Research Foundation | Biodegradable microspheres as a carrier for macromolecules |
IL82834A (en) | 1987-06-09 | 1990-11-05 | Yissum Res Dev Co | Biodegradable polymeric materials based on polyether glycols,processes for the preparation thereof and surgical artiicles made therefrom |
US4938763B1 (en) | 1988-10-03 | 1995-07-04 | Atrix Lab Inc | Biodegradable in-situ forming implants and method of producing the same |
US5162430A (en) | 1988-11-21 | 1992-11-10 | Collagen Corporation | Collagen-polymer conjugates |
US5304595A (en) | 1988-11-21 | 1994-04-19 | Collagen Corporation | Collagen-polymer conjugates |
IL90193A (en) | 1989-05-04 | 1993-02-21 | Biomedical Polymers Int | Polurethane-based polymeric materials and biomedical articles and pharmaceutical compositions utilizing the same |
US5410016A (en) | 1990-10-15 | 1995-04-25 | Board Of Regents, The University Of Texas System | Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers |
JP3165734B2 (ja) * | 1992-05-19 | 2001-05-14 | テルモ株式会社 | 新規な高吸水形状記憶材料 |
US5304959A (en) | 1992-10-16 | 1994-04-19 | Spectrian, Inc. | Planar microstrip balun |
US6371975B2 (en) | 1998-11-06 | 2002-04-16 | Neomend, Inc. | Compositions, systems, and methods for creating in situ, chemically cross-linked, mechanical barriers |
EP1027016A4 (en) | 1997-10-27 | 2006-03-08 | Univ California | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR REFERRING RETINAL RIPPLE |
US6152943A (en) | 1998-08-14 | 2000-11-28 | Incept Llc | Methods and apparatus for intraluminal deposition of hydrogels |
US6514534B1 (en) | 1998-08-14 | 2003-02-04 | Incept Llc | Methods for forming regional tissue adherent barriers and drug delivery systems |
US6605294B2 (en) | 1998-08-14 | 2003-08-12 | Incept Llc | Methods of using in situ hydration of hydrogel articles for sealing or augmentation of tissue or vessels |
US6632457B1 (en) | 1998-08-14 | 2003-10-14 | Incept Llc | Composite hydrogel drug delivery systems |
EP1137373A4 (en) | 1998-12-04 | 2004-05-19 | Chandrashekhar P Pathak | BIOCOMPATIBLE, CROSSLINKED POLYMERS |
US6958212B1 (en) | 1999-02-01 | 2005-10-25 | Eidgenossische Technische Hochschule Zurich | Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds |
ES2312456T3 (es) | 2000-08-30 | 2009-03-01 | Johns Hopkins University | Dispositivos para suministro intraocular de farmacos. |
WO2002067908A1 (en) | 2001-02-26 | 2002-09-06 | Duke University | Novel dendritic polymers and their biomedical uses |
US20040131582A1 (en) | 2002-02-26 | 2004-07-08 | Grinstaff Mark W. | Novel dendritic polymers and their biomedical uses |
US7129210B2 (en) | 2003-07-23 | 2006-10-31 | Covalent Medical, Inc. | Tissue adhesive sealant |
WO2005027906A1 (en) * | 2003-09-18 | 2005-03-31 | Macusight, Inc. | Transscleral delivery |
WO2006031358A2 (en) | 2004-08-13 | 2006-03-23 | Hyperbranch Medical Technology, Inc. | Dendritic polymers, crosslinked gels, and their uses as ophthalmic sealants and lenses |
WO2006031388A2 (en) | 2004-08-20 | 2006-03-23 | Hyperbranch Medical Technology, Inc. | Dentritic polymers, crosslinked gels, and their uses in orthopedic applications |
WO2007001926A2 (en) | 2005-06-24 | 2007-01-04 | Hyperbranch Medical Technology, Inc. | Low-swelling hydrogel sealants for wound repair |
WO2007005249A2 (en) | 2005-06-29 | 2007-01-11 | Hyperbranch Medical Technology, Inc. | Nanoparticles and dendritic-polymer-based hydrogels comprising them |
US8795709B2 (en) | 2006-03-29 | 2014-08-05 | Incept Llc | Superabsorbent, freeze dried hydrogels for medical applications |
US20080220047A1 (en) | 2007-03-05 | 2008-09-11 | Sawhney Amarpreet S | Low-swelling biocompatible hydrogels |
US20080287633A1 (en) * | 2007-05-18 | 2008-11-20 | Drumheller Paul D | Hydrogel Materials |
US9125807B2 (en) | 2007-07-09 | 2015-09-08 | Incept Llc | Adhesive hydrogels for ophthalmic drug delivery |
JP5890182B2 (ja) * | 2009-02-12 | 2016-03-22 | インセプト エルエルシー | ヒドロゲルプラグによる薬物送達 |
CA3042067C (en) | 2009-12-15 | 2022-10-18 | Incept, Llc | Implants and biodegradable fiducial markers |
US8961501B2 (en) | 2010-09-17 | 2015-02-24 | Incept, Llc | Method for applying flowable hydrogels to a cornea |
EP2699317B1 (en) | 2011-04-21 | 2016-08-10 | Mapi Pharma Limited | Random pentapolymer for treatment of autoimmune diseases |
WO2012150265A1 (en) * | 2011-05-02 | 2012-11-08 | Dsm Ip Assets B.V. | Fiber comprising a biodegradable polymer |
CN103917202B (zh) | 2011-09-14 | 2016-06-29 | 弗赛特影像5股份有限公司 | 眼插入件装置和方法 |
US10226417B2 (en) | 2011-09-16 | 2019-03-12 | Peter Jarrett | Drug delivery systems and applications |
KR20190090048A (ko) | 2011-12-05 | 2019-07-31 | 인셉트, 엘엘씨 | 의료용 유기젤 방법 및 조성물 |
EP2911623B1 (en) | 2012-10-26 | 2019-08-14 | Forsight Vision5, Inc. | Ophthalmic system for sustained release of drug to eye |
JP7092502B2 (ja) | 2014-12-10 | 2022-06-28 | インセプト・リミテッド・ライアビリティ・カンパニー | ハイドロゲル薬物送達インプラント |
EP4279064A3 (en) | 2015-05-12 | 2024-02-28 | Incept, LLC | Drug delivery from hydrogels |
JP2018525078A (ja) | 2015-07-22 | 2018-09-06 | インセプト・リミテッド・ライアビリティ・カンパニーIncept,Llc | 被覆された涙点プラグ |
JP2018536484A (ja) * | 2015-11-25 | 2018-12-13 | インセプト・リミテッド・ライアビリティ・カンパニーIncept,Llc | 形状変化する薬物送達デバイス及び方法 |
-
2016
- 2016-11-23 JP JP2018526903A patent/JP2018536484A/ja active Pending
- 2016-11-23 EP EP16816493.7A patent/EP3380077A1/en active Pending
- 2016-11-23 US US15/360,430 patent/US10420724B2/en active Active
- 2016-11-23 CN CN201680078805.5A patent/CN108601725B/zh active Active
- 2016-11-23 KR KR1020187017686A patent/KR20180086468A/ko active Search and Examination
- 2016-11-23 WO PCT/US2016/063633 patent/WO2017091749A1/en active Application Filing
- 2016-11-23 CA CA3006303A patent/CA3006303C/en active Active
- 2016-11-23 AU AU2016361579A patent/AU2016361579B2/en active Active
- 2016-11-23 BR BR112018010671A patent/BR112018010671A8/pt not_active Application Discontinuation
-
2018
- 2018-05-22 IL IL259530A patent/IL259530A/en unknown
-
2019
- 2019-08-06 US US16/533,331 patent/US10786462B2/en active Active
-
2020
- 2020-08-21 US US16/999,504 patent/US11413250B2/en active Active
-
2022
- 2022-07-07 US US17/859,820 patent/US11938223B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US10786462B2 (en) | 2020-09-29 |
KR20180086468A (ko) | 2018-07-31 |
CA3006303A1 (en) | 2017-06-01 |
US10420724B2 (en) | 2019-09-24 |
AU2016361579A1 (en) | 2018-06-21 |
US20220339108A1 (en) | 2022-10-27 |
EP3380077A1 (en) | 2018-10-03 |
CN108601725B (zh) | 2024-03-08 |
US11938223B2 (en) | 2024-03-26 |
CN108601725A (zh) | 2018-09-28 |
US11413250B2 (en) | 2022-08-16 |
US20170143636A1 (en) | 2017-05-25 |
IL259530A (en) | 2018-07-31 |
US20200030241A1 (en) | 2020-01-30 |
JP2018536484A (ja) | 2018-12-13 |
WO2017091749A1 (en) | 2017-06-01 |
US20210128478A1 (en) | 2021-05-06 |
CA3006303C (en) | 2023-11-14 |
BR112018010671A2 (pt) | 2018-11-13 |
AU2016361579B2 (en) | 2022-08-04 |
WO2017091749A8 (en) | 2017-07-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112018010671A2 (pt) | dispositivos e métodos de distribuição de fármaco com mudança de forma | |
NI201600071A (es) | Compuestos de inhibidor de autotaxina | |
CY1124729T1 (el) | Φαρμακοτεχνικες μορφες του ενζαλουταμιδιου | |
BR112018076601A2 (pt) | formulação farmacêutica oral, métodos para tratar um paciente, e, uso de uma formulação | |
BR112017005693A2 (pt) | método para tratar e/ou prevenir uma doença hepática, e, composição farmacêutica. | |
BR112016020618A8 (pt) | oligômero antissentido, composição farmacêutica, e, uso de um oligômero antissentido | |
CL2016001609A1 (es) | Composiciones farmacéuticas que comprenden azd9291. | |
CR20150326A (es) | Inhibidores de autotaxina | |
NI201600051A (es) | Combinaciones de inhibidores de histona desacetilasa y farmacos inmunomoduladores | |
BR112015022625A2 (pt) | micromatrizes para entrega de agente terapêutico e métodos de uso | |
DK3419699T3 (da) | Dosisstyresystem til injicerbare lægemiddelafgivelsesindretninger og tilknyttede fremgangsmåder til anvendelse | |
BR112016002646A2 (pt) | dispositivos e métodos de entrega de fármaco de múltiplas unidades | |
CL2015002733A1 (es) | Composición farmacéutica de clorhidrato de s-cetamina. | |
DK3193981T3 (da) | Medikamentadministrationsanordning i form af voluminøst hudplaster med integreret mekanisme til hudsterilisering af injektionssted | |
MX2020002693A (es) | Formulaciones farmaceuticas estabilizadas de analogos de insulina y/o derivados de insulina. | |
NI201600070A (es) | Inhibidores tetracíclicos de autotaxina | |
ZA201508454B (en) | Method of applying a composition and pharmaceutical composition with a regimen of administering it, including photo-activating the active component | |
CO2017002472A2 (es) | Formulación de acetato de abiraterona | |
CL2015002180A1 (es) | Terapia de combinación para el tratamiento de neumonía nosocomial | |
CL2014003148A1 (es) | Composición farmacéutica acuosa que contiene un agente terapéutico biológico y guanidina o un derivado de la guanidina y una inyección que incluye la composición. | |
DK3432970T3 (da) | In vivo lægemiddelleveringsindretninger | |
BR112017012406A2 (pt) | formulação com relação fixa de insulina glargina/lixisenatida | |
ECSP16086247A (es) | (s)-pirlindole y sus sales farmacéuticamente aceptables para uso en medicina | |
BR112017024908A2 (pt) | usos terapêuticos da 4-cloroquinurenina | |
CL2016001098A1 (es) | Uso de cisteamina y sus derivados para el tratamiento de enfermedades mitocondriales |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] |
Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO EM FUNCAO DA REVOGACAO DO ART. 229-C DA LEI NO 9.279, DE 1996, POR FORCA DA LEI NO 14.195, DE 2021 |
|
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |